Elstar Therapeutics: Big Pharma vets bag $39M to drive I/O firm Elstar forward
Elstar Therapeutics has raised $39 million. The series A positions a management team with résumés dotted with senior posts at Serono, Eli Lilly and Novartis to advance multifunctional anti-cancer drugs toward human testing.
Read full article »
Elstar Therapeutics develops multi-functional antibody therapies for the treatment of cancer, inflammatory and immunological diseases.
Read more